The three RAS oncogenes (HRAS, KRAS and NRAS) are part of the most frequently mutated gene family in human cancer, since over 20% of human cancers harbor mutations in one of the three RAS genes, making them the most prevalent oncogenic drivers [13]. This evidence concerns the gene NRAS and cancer.